J&J Hopes To Win Back Prestige Case After Judge Favors Home Diagnostics
This article was originally published in The Gray Sheet
Executive Summary
Johnson & Johnson's LifeScan subsidiary plans to appeal a June 21 ruling by a Delaware district court that Home Diagnostics Inc.' s Prestige blood glucose test system does not infringe J&J patents.